Production of recombinant protein therapeutics in cultivated mammalian cells
Open accessThe DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Abstract
Cultivated mammalian cells have become the dominant system for the production of recombinant proteins for clinical applications because of their capacity for proper protein folding, assembly and post-translational modification. Thus, the quality and efficacy of a protein can be superior when expressed in mammalian cells versus other hosts such as bacteria, plants and yeast. Recently, the productivity of mammalian cells cultivated in bioreactors has reached the gram per liter range in a number of cases, a more than 100-fold yield improvement over titers seen for similar processes in the mid-1980s. This increase in volumetric productivity has resulted mainly from improvements in media composition and process control. Opportunities still exist for improving mammalian cell systems through further advancements in production systems as well as through vector and host cell engineering.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Advances in cell engineering, process control, and media composition are credited with improving the volumetric yield of cell culture bioprocesses, making biopharmaceutical manufacturing more cost-effective and practical [8].”
From The role of Raman spectroscopy in biopharmaceuticals from development to manufacturing (2022) · cites this paper as [8]
In the citing paper
“Chinese hamster ovary (CHO) cells are one of the main cell lines used in the production of recombinant therapeutics (Wurm, 2004; see Grillberger et al., 2009 for examples of proteins produced in CHO cells).”
From Virus susceptibility of Chinese hamster ovary (CHO) cells and detection of viral contaminations by adventitious agent testing (2010) · cites this paper as Wurm, 2004
Citations
Cites
A new technique for the assay of infectivity of human adenovirus 5 DNA
Graham, F. L., & van der Eb, A. J. (1973) · Virology · doi:10.1016/0042-6822(73)90341-3 · Cited by 9,451 · cited 1×
“In 1973, Graham and van der Eb showed that exposing cells to nanoparticles of DNA and calcium phosphate makes possible DNA transfer into cultivated mammalian cell”
BackgroundEpigenetic Codes for Heterochromatin Formation and Silencing
Richards, E. J., & Elgin, S. C. R. (2002) · Cell · doi:10.1016/s0092-8674(02)00644-x · Cited by 871
Umaña, P., Jean–Mairet, J., Moudry, R., Amstutz, H., & Bailey, J. E. (1999) · Nature Biotechnology · doi:10.1038/6179 · Cited by 764
How introns influence and enhance eukaryotic gene expression
Le Hir, H., Nott, A., & Moore, M. J. (2003) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(03)00052-5 · Cited by 734
Bebbington, C. R., Renner, G., Thomson, S., King, D., Abrams, D., & Yarranton, G. T. (1992) · Nature Biotechnology · doi:10.1038/nbt0292-169 · Cited by 462 · cited 1×
“At a concentration of 10–100 μM MSX, resistant clones can be identified in selected NS0 cell populations that have amplified the transgene complex containing the GS gene and the desired gene(s) of interes”
BackgroundGenetic and physical linkage of exogenous sequences in transformed cells
Perucho, M., Hanahan, D., & Wigler, M. (1980) · Cell · doi:10.1016/0092-8674(80)90178-6 · Cited by 455 · cited 1×
“Nuclear ligases assure the covalent joining of individual plasmid DNA molecule”
BackgroundExpression of recombinant plasmids in mammalian cells Is enhanced by sodium butyrate
Gorman, C. M., Howard, B. H., & Reeves, R. (1983) · Nucleic Acids Research · doi:10.1093/nar/11.21.7631 · Cited by 367 · cited 1×
“Another way to inhibit silencing is to block deacetylation of histones using butyrat”
BackgroundSilencing of transgene transcription precedes methylation of promoter DNA and histone H3 lysine 9
Mutskov, V., & Felsenfeld, G. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600013 · Cited by 296
Kim, S. J., Kim, N. S., Ryu, C. J., Hong, H. J., & Lee, G. M. (1998) · Biotechnology and Bioengineering · doi:10.1002/(sici)1097-0290(19980405)58:1<73::aid-bit8>3.0.co;2-r · Cited by 220 · cited 1×
“Thus, it might be advantageous to omit selective drugs once promising clonal cell lines have been identifie”
BackgroundLarge-scale transient expression in mammalian cells for recombinant protein production
Wurm, F., & Bernard, A. (1999) · Current Opinion in Biotechnology · doi:10.1016/s0958-1669(99)80027-5 · Cited by 203
Self-citation
Research works printed but not linked: 1
- Gorman, C.M., Howard, B.H. & Reeves, R. Expression of recombinant plasmids in mammalian cells is enhanced by sodium butyrate. Nucleic Acids Res. 11, 7631–7648 (1983). · DOI · Paper page
Cited by
Items 501–600 of 1,007
Rajendra, Y., Kiseljak, D., Manoli, S. S., Baldi, L., Hacker, D. L., & Wurm, F. M. (2012) · Biotechnology and Bioengineering · doi:10.1002/bit.24494 · Cited by 42
Self-citationEfficient Recombinant Production in Mammalian Cells Using a Novel IR/MAR Gene Amplification Method
Araki, Y., Hamafuji, T., Noguchi, C., & Shimizu, N. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041787 · Cited by 41
“Industrial production of recombinant protein in these cells is a multi-part process and entails the development of high-producer cells, culture of the cells at high density in chemically defined medium, and purification of the target protein (reviewed in [1]).”
BackgroundMethodAnuraj, N., Bhattacharjee, S., Geiger, J. H., Baker, G. L., & Bruening, M. L. (2011) · Journal of Membrane Science · doi:10.1016/j.memsci.2011.10.022 · Cited by 41
“Although rapid advances in biotechnology have greatly increased the synthesis and applications of recombinant proteins, isolation of these proteins remains a bottleneck in their production [1, 2].”
BackgroundWang, L., Hu, H., Yang, J., Wang, F., Kaisermayer, C., & Zhou, P. (2011) · Molecular Biotechnology · doi:10.1007/s12033-011-9484-5 · Cited by 46
“C6 cell lines over 5 g/l level of the complete antibody production in fed-batch using shake flasks or horizontally oscillating bioreactors was reported [7, 39, 41].”
BackgroundMethodLi, S., Cohen-Karni, D., Beringer, L. T., Wu, C., Kallick, E., Edington, H. J. D., Passineau, M. J., & Averick, S. E. (2016) · Polymer · doi:10.1016/j.polymer.2016.06.059 · Cited by 42
RNA‐Seq Highlights High Clonal Variation in Monoclonal Antibody Producing CHO Cells
Orellana, C. A., Marcellin, E., Palfreyman, R. W., Munro, T. P., Gray, P. P., & Nielsen, L. K. (2018) · Biotechnology Journal · doi:10.1002/biot.201700231 · Cited by 46
Mild hypothermia upregulates myc and xbp1s expression and improves anti-TNFα production in CHO cells
Torres, M., Zúñiga, R., Gutiérrez-González, M., Vergara, M., Collazo, N., Reyes, J. G., Berríos, J., Aguillón, J. C., Molina, M. C., & Altamirano, C. (2018) · PLoS ONE · doi:10.1371/journal.pone.0194510 · Cited by 43
Jia, Y., Guo, X. H., Lu, J., Wang, X., Qiu, L., & Wang, T. (2018) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13687 · Cited by 44
“Therefore, recombinant protein production is still challenged by the lack of cell lines that can achieve both high production and stability.(6,7)”
BackgroundHilliard, W., & Lee, K. H. (2020) · Biotechnology and Bioengineering · doi:10.1002/bit.27599 · Cited by 60
“Random transgene integration is the most commonly used method for establishing CHO cell lines capable of producing therapeutic proteins at industrially relevant bioreactor yields of multiple grams per liter (F. M. Wurm, 2004).”
MethodZhao, Y., Vanderkooi, S., & Kan, F. W. K. (2022) · Histochemistry and Cell Biology · doi:10.1007/s00418-021-02065-x · Cited by 41
The heterogeneous nature of polyethylenimine-DNA complex formation affects transient gene expression
Han, X., Fang, Q., Yao, F., Wang, X., Wang, J., Yang, S., & Shen, B. Q. (2009) · Cytotechnology · doi:10.1007/s10616-009-9215-y · Cited by 41
“Serving primarily as an alternative tool for recombinant protein preparation, however, these processes have generally been found to be relatively less productive compared to those of wellestablished stable expression systems such as CHO and NS0 cells (Girard et al. 2002; Wurm 2004; Baldi et al. 2005).”
BackgroundGeneration of monoclonal antibody-producing mammalian cell lines
Ho, S. C., Tong, Y. W., & Yang, Y. (2013) · Pharmaceutical Bioprocessing · doi:10.4155/pbp.13.8 · Cited by 46
“150 Matasci M, Baldi L, Hacker DL, Wurm FM. The PiggyBac transposon enhances the frequency of CHO stable cell line generation and yields recombinant lines with superior productivity and stability. Biotechnol. Bioeng. 108(9), 2141–2150 (2011).”
BackgroundChen, F., Kou, T.-C., Li, F., Zhou, Y., Ye, Z., Zhao, L., & Tan, W. (2011) · Biotechnology and Bioprocess Engineering · doi:10.1007/s12257-011-0069-8 · Cited by 50
Engineering of chaperone systems and of the unfolded protein response
Khan, S. U., & Schröder, M. (2008) · Cytotechnology · doi:10.1007/s10616-008-9157-9 · Cited by 52
“Considering the already high cell specific productivities of many (Dinnis and James 2005; Robinson and Memmert 1991; Wurm 2004), but not all (Ailor and Reff 2005), antibody expression systems, engineering of ER-resident chaperone systems and the UPR to increase cell specific productivities will be especially important…”
BackgroundHa, T. K., Hansen, A. H., Kol, S., Kildegaard, H. F., & Lee, G. M. (2018) · Biotechnology Journal · doi:10.1002/biot.201700425 · Cited by 40
“Chinese hamster ovary (CHO) cells are the most widely used mammalian host cell lines for the commercial production of recombinant therapeutic proteins, including monoclonal antibodies (mAbs) [1, 2].”
BackgroundProtein-Specific Signal Peptides for Mammalian Vector Engineering
O’Neill, P., Mistry, R. K., Brown, A. J., & James, D. C. (2023) · ACS Synthetic Biology · doi:10.1021/acssynbio.3c00157 · Cited by 40
“Over the past two decades significant titre increases have been achieved via cell [2], vector [3], process [4] and media [5] engineering.”
Protein drug delivery: current dosage form profile and formulation strategies
Geraldes, D. C., Beraldo-de-Araújo, V. L., Pardo, B. O. P., Pessoa, A., Stephano, M. A., & Nascimento, L. D. O. (2019) · Journal of drug targeting · doi:10.1080/1061186x.2019.1669043 · Cited by 40
Progress toward Eukaryotic Semisynthetic Organisms: Translation of Unnatural Codons
Zhou, A. X.-Z., Sheng, K., Feldman, A. W., & Romesberg, F. E. (2019) · Journal of the American Chemical Society · doi:10.1021/jacs.9b09080 · Cited by 42
Berger, A., Fourn, V. L., Masternak, J., Regamey, A., Bodenmann, I., Girod, P., & Mermod, N. (2020) · Biotechnology and Bioengineering · doi:10.1002/bit.27274 · Cited by 42
Schmieder, V., Fieder, J., Drerup, R., Gutierrez, E. A., Guelch, C., Stolzenberger, J., Stumbaum, M., Mueller, V. S., Higel, F., Bergbauer, M., et al. (2022) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2022.03.010 · Cited by 40
Schaub, J., Clemens, C., Kaufmann, H., & Schulz, T. W. (2011) · Springer eBooks · doi:10.1007/10_2010_98 · Cited by 48
“Development of efficient bioprocesses requires high-producer cell lines, powerful cell culture media, and adequate process control strategies [1–3].”
BackgroundSelvarasu, S., Kim, D. Y., Karimi, I. A., & Lee, D. (2010) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2010.07.016 · Cited by 47
Improved antibody production in Chinese hamster ovary cells by ATF4 overexpression
Haredy, A. M., Nishizawa, A., Honda, K., Ohya, T., Ohtake, H., & Ōmasa, T. (2013) · Cytotechnology · doi:10.1007/s10616-013-9631-x · Cited by 45
Kang, S., Mullen, J., Miranda, L. P., & Deshpande, R. R. (2012) · Biotechnology and Bioengineering · doi:10.1002/bit.24507 · Cited by 40
Unnatural Amino Acids in Novel Antibody Conjugates
Hallam, T. J., & Smider, V. V. (2014) · Future Medicinal Chemistry · doi:10.4155/fmc.14.79 · Cited by 43
Factors of importance for a successful delivery system for proteins
van de Weert, M., Jørgensen, L., Moeller, E. H., & Frøkjær, S. (2005) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2.6.1029 · Cited by 40
“At present, most protein drugs are produced in mammalian cell cultures [5-7], but other expression systems are actively being explored [8].”
BackgroundLensless multispectral digital in-line holographic microscope
Ryle, J. P., Sheridan, J. T., & McDonnell, S. (2011) · Journal of Biomedical Optics · doi:10.1117/1.3659681 · Cited by 39
Giese, G. S., Myrold, A., Gorrell, J., & Persson, J. (2013) · Journal of Chromatography B · doi:10.1016/j.jchromb.2013.08.029 · Cited by 39
Dynamic gene expression for metabolic engineering of mammalian cells in culture
Le, H., Vishwanathan, N., Kantardjieff, A., Doo, I., Srienc, M., Zheng, X., Somia, N. V., & Hu, W. (2013) · Metabolic Engineering · doi:10.1016/j.ymben.2013.09.004 · Cited by 42
Liu, Z., Dai, S., Bones, J., Ray, S., Cha, S., Karger, B. L., Li, J. J., Wilson, L., Hinkle, G., & Rossomando, A. J. (2015) · Biotechnology Progress · doi:10.1002/btpr.2090 · Cited by 44
“achieve high specific productivity with enhanced cell density of viable cells and culture longevity.(11) It is, therefore, impor-”
BackgroundN-glycan analysis of human α1-antitrypsin produced in Chinese hamster ovary cells
Lee, K. J., Lee, S. M., Gil, J. Y., Kwon, O., Kim, J. Y., Park, S. J., Chung, H.-S., & Oh, D. (2012) · Glycoconjugate Journal · doi:10.1007/s10719-012-9453-7 · Cited by 41
Karlsson, J. E., Heddle, C., Rozkov, A., Rotticci-Mulder, J., Tuvesson, O., Hilgendorf, C., & Andersson, T. B. (2010) · Drug Metabolism and Disposition · doi:10.1124/dmd.109.028886 · Cited by 39
“, 2008, 2009) and has been used widely for expression of various recombinant proteins (Wurm, 2004).”
BackgroundKaneyoshi, K., Kuroda, K., Uchiyama, K., Onitsuka, M., Yamano, N., Koga, Y., & Ōmasa, T. (2019) · Cytotechnology · doi:10.1007/s10616-018-0286-5 · Cited by 43
“…Tokushima 7708513, Japan M. Onitsuka N. Yamano-Adachi T. Omasa Manufacturing Technology Association of Biologics, 7-1-49 Minatojima-minami, Kobe, Hyogo 6500047, Japan proteins (Wurm 2004; Li et al. 2010; Bandaranayake and Almo 2014; Kunert and Reinhart 2016; Takagi et al. 2017; Kuwae et al. 2018).”
BackgroundAn overview of the bacterial SsrA system modulating intracellular protein levels and activities
Fritze, J. S., Zhang, M., Luo, Q., & Lü, X. (2020) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-020-10623-x · Cited by 40
“Escherichia coli and yeast) is increasingly used to obtain sufficient amount of target proteins for studying their biochemical, structural, and functional characteristics, clinical purposes, and emerging applications like new biomaterials (Choi et al. 2018; Daumy et al. 1989; Kim et al. 2001; Wurm 2004).”
Makvandi‐Nejad, S., McLean, M. D., Hirama, T., Almquist, K. C., MacKenzie, C. R., & Hall, J. C. (2005) · Transgenic Research · doi:10.1007/s11248-005-7461-0 · Cited by 44
“Finally, mammalian cells are the pharmaceutical industry standard for mAb production ( Wurm, 2004 ), but this process can be expensive and slow (Schillberg et al., 2002).”
BackgroundCarlage, T., Kshirsagar, R., Zang, L., Janakiraman, V., Hincapie, M., Lyubarskaya, Y., Weiskopf, A., & Hancock, W. S. (2012) · Biotechnology Progress · doi:10.1002/btpr.1534 · Cited by 38
“The factors controlling this transition are not well understood; possible explanations include limitation of key metabolites, accumulation of toxic waste products, or cellular response to endoplasmic reticulum (ER) stress.(13,15) However, the transition from exponential to stationary phases has a significant impact on…”
BackgroundQuantifying the impact of cell culture media on CHO cell growth and protein production
Combe, M., & Sokolenko, S. (2021) · Biotechnology Advances · doi:10.1016/j.biotechadv.2021.107761 · Cited by 42
Diverse origins of fibrinolytic enzymes: A comprehensive review
Hazare, C., Bhagwat, P. K., Singh, S., & Pillai, S. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e26668 · Cited by 43
“In 1986, human t-PA became the first therapeutic protein from recombinant mammalian cells to obtain market C. Hazare et al. approval [84].”
BackgroundLink, N., Brunner, T. J., Dreesen, I. A. J., Stark, W. J., & Fussenegger, M. (2007) · Biotechnology and Bioengineering · doi:10.1002/bit.21525 · Cited by 38
Bioreactors for Mammalian Cells
Pörtner, R. (2014) · Cell engineering · doi:10.1007/978-3-319-10320-4_4 · Cited by 42
Knevelman, C., Davies, J., Allen, L., & Titchener-Hooker, N. J. (2009) · Biotechnology Progress · doi:10.1002/btpr.357 · Cited by 38
“Considerable efforts focused on upstream cell culture development over the last two decades have resulted in a significant rise in mAb titers from a few milligrams per liter to grams per liter concentrations.(2) Conventionally, upstream titer increases have shown a direct correlation with downstream processing volumes.”
BackgroundMetabolic control at the cytosol–mitochondria interface in different growth phases of CHO cells
Wahrheit, J., Niklas, J., & Heinzle, E. (2014) · Metabolic Engineering · doi:10.1016/j.ymben.2014.02.001 · Cited by 49
“1 Present address: Insilico Biotechnology AG, Meitnerstraße 8, D-70563 Stuttgart, Germany. for the biopharmaceutical industry serving as the predominant cultivation system for the production of therapeutic proteins (Wurm, 2004).”
BackgroundSystems biotechnology of animal cells: the road to prediction
Carinhas, N., Oliveira, R., Alves, P. M., Carrondo, M. J. T., & Teixeira, A. P. (2012) · Trends in biotechnology · doi:10.1016/j.tibtech.2012.03.004 · Cited by 46
Generation of stable cell clones expressing mixtures of human antibodies
de Kruif, J., Kramer, A., Nijhuis, R., der Zande, V. Z.-V., den Blanken-Smit, R., Clements, C., Visser, T., Keehnen, R., den Hartog, M., Throsby, M., et al. (2010) · Biotechnology and Bioengineering · doi:10.1002/bit.22763 · Cited by 38
“…of production instability, however the ‘‘positional effect’’ can also have a major effect on the transcription rate as transgenes can be rapidly silenced by the influence of neighboring heterochromatin that make them inaccessible for transcriptional machinery (Chusainow et al., 2008; Wurm, 2004).”
BackgroundMethodInfluentialLow Level Sequence Variant Analysis of Recombinant Proteins: An Optimized Approach
Zeck, A., Regula, J. T., Larraillet, V., Mautz, B., Popp, O., Göpfert, U., Wiegeshoff, F., Vollertsen, U. E. E., Gorr, I. H., Koll, H., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040328 · Cited by 40
Wilkens, C. A., & Gerdtzen, Z. P. (2015) · PLoS ONE · doi:10.1371/journal.pone.0119053 · Cited by 44
“A cell engineering approach has been proposed to improve cell metabolism, overexpressing or knocking down key genes involved in the central carbon metabolism [5,6].”
BackgroundDroplet size influences division of mammalian cell factories in droplet microfluidic cultivation
Rajeswari, P. K. P., Joensson, H. N., & Svahn, H. A. (2016) · Electrophoresis · doi:10.1002/elps.201600316 · Cited by 38
Generation of High Expressing Chinese Hamster Ovary Cell Pools Using the Leap‐In Transposon System
Balasubramanian, S., Peery, R. B., Minshull, J., Lee, M., White, R. N., Kelly, R. M., & Barnard, G. C. (2018) · Biotechnology Journal · doi:10.1002/biot.201700748 · Cited by 38
Dhiman, H., Campbell, M., Melcher, M., Smith, K. D., & Borth, N. (2020) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2020.11.008 · Cited by 43
“The production of biologically active forms of tissue plasminogen activator (tPA) using CHO cells in 1987 marked the beginning of the CHO-based therapeutics era [3].”
BackgroundPlant Platforms for Efficient Heterologous Protein Production
Ghag, S. B., Adki, V. S., Ganapathi, T. R., & Bapat, V. A. (2021) · Biotechnology and Bioprocess Engineering · doi:10.1007/s12257-020-0374-1 · Cited by 39
“Bacterial [13], fungal [14,15], plant [16], and animal systems [17,18] have been used since 1970s to produce a variety of recombinant proteins and later explored to produce biopharmaceuticals in addition to industrially relevant proteins.”
BackgroundUsing microarray technology to select housekeeping genes in Chinese hamster ovary cells
Bahr, S. M., Borgschulte, T., Kayser, K. J., & Lin, N. (2009) · Biotechnology and Bioengineering · doi:10.1002/bit.22452 · Cited by 37
Griaud, F., Denefeld, B., Lang, M., Hensinger, H., Haberl, P., & Berg, M. (2017) · mAbs · doi:10.1080/19420862.2017.1313367 · Cited by 38
“Typically, these biomolecules are expressed at high titer in stable transfected mammalian cell lines like immortalized Chinese hamster ovary (CHO) cells.(4) Although the primary structure of the mAbs is unequivocally transcribed and translated from the coding DNA and mRNA sequences, respectively, the resulting drug su…”
BackgroundRemli, M. A., Deris, S., Mohamad, M. S., Omatu, S., & Corchado, J. M. (2017) · Engineering Applications of Artificial Intelligence · doi:10.1016/j.engappai.2017.04.004 · Cited by 38
Li, Q., Lin, H., Du, Q., Liu, K., Wang, O., Evans, C. S., Christian, H., Zhang, C., & Lei, Y. (2018) · Biofabrication · doi:10.1088/1758-5090/aaa6b5 · Cited by 42
Harraghy, N., Regamey, A., Girod, P.-A., & Mermod, N. (2011) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2011.04.004 · Cited by 37
Precision control of recombinant gene transcription for CHO cell synthetic biology
Brown, A. J., & James, D. C. (2015) · Biotechnology Advances · doi:10.1016/j.biotechadv.2015.12.012 · Cited by 40
“…as: Brown, A.J., James, D.C., Precision control of reco Adv (2015), http://dx.doi.org/10.1016/j.biotechadv.2015.12.012 an external, multi-component synthetic environments for CHO cells (e.g.media/feed/process composition), which havemassively improved functional performance (Wurm, 2004; Zhu, 2012).”
BackgroundInfluentialVenereo-Sánchez, A., Simoneau, M., Lanthier, S., Chahal, P. S., Bourget, L., Ansorge, S., Gilbert, R., Henry, O., & Kamen, A. (2017) · Vaccine · doi:10.1016/j.vaccine.2017.06.024 · Cited by 43
“The transgenes can be inserted in zones of the chromatin more or less active and/or the insertion of ‘‘multiple gene copies can unpredictably cross-interact” [29] influencing the protein expression [30].”
BackgroundHoshino, Y., Taniguchi, S., Takimoto, H., Akashi, S., Katakami, S., Yonamine, Y., & Miura, Y. (2019) · Angewandte Chemie International Edition · doi:10.1002/anie.201910558 · Cited by 38
Dorai, H., Csirke, B., Scallon, B., & Ganguly, S. (2006) · Hybridoma · doi:10.1089/hyb.2006.25.1 · Cited by 37
Majid, F. A. A., Butler, M., & Al‐Rubeai, M. (2007) · Biotechnology and Bioengineering · doi:10.1002/bit.21207 · Cited by 34
“…Inc. KEYWORDS: apoptosis; bcl-2; cell culture; IgG; glycosylation; galactosylation; hybridoma The maximisation of productivity in mammalian cell cultures has been a vital goal for economically viable manufacture of biotherapeutics (Butler, 2005; Warnock and Al-Rubeai, 2006; Wurm, 2004).”
BackgroundJuárez, P., Virdi, V., Depicker, A., & Orzáez, D. (2016) · Plant Biotechnology Journal · doi:10.1111/pbi.12541 · Cited by 37
“Although mammalian cells (Wurm, 2004) or baculovirusinfected insect cells (Berger et al.”
BackgroundLin, H., Qiu, X., Du, Q., Li, Q., Wang, O., Akert, L., Wang, Z., Anderson, D. K., Liu, K., Gu, L., et al. (2018) · Stem Cell Reports · doi:10.1016/j.stemcr.2018.11.009 · Cited by 39
E2F-1 overexpression increases viable cell density in batch cultures of Chinese hamster ovary cells
Majors, B. S., Arden, N., Oyler, G. A., Chiang, G. G., Pederson, N. E., & Betenbaugh, M. J. (2008) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2008.08.003 · Cited by 36
“While microbial cultures can obtain a packed cell volume of 30%, current mammalian culture systems only achieve packed cell volumes of less than 3%, even with cultures containing tens of millions of cells (Wurm, 2004).”
BackgroundOnline- and offline- monitoring of stem cell expansion on microcarrier
Justice, C., Leber, J., Freimark, D., Pino-Grace, P. P., Kraume, M., & Czermak, P. (2011) · Cytotechnology · doi:10.1007/s10616-011-9359-4 · Cited by 36
“Cells or cell related products, which work as biopharmaceuticals must satisfy GMP guidelines given by the authorities ( Wurm 2004; Baldi et al. 2007; Butler 2005; Weber et al. 2007a, b, 2009).”
BackgroundRole of plant expression systems in antibody production for passive immunization
Virdi, V., & Depicker, A. (2013) · The International Journal of Developmental Biology · doi:10.1387/ijdb.130266ad · Cited by 36
“The yield of the antibodies produced in mammalian cells has increased more than 10-fold (more than 5 g/L) since the 1980s (Wurm, 2004).”
BackgroundPieper, L. A., Strotbek, M., Wenger, T., Olayioye, M. A., & Haußer, A. (2017) · Biotechnology and Bioengineering · doi:10.1002/bit.26263 · Cited by 40
Yeo, J. H. M., Ho, S. C. L., Mariati, M., Koh, E. Y. C., Tay, S. J., Woen, S., Zhang, P., & Yang, Y. (2017) · Biotechnology Journal · doi:10.1002/biot.201700175 · Cited by 39
Lin, H., Du, Q., Li, Q., Wang, O., Wang, Z., Liu, K., Elowsky, C. G., Zhang, C., & Lei, Y. (2018) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.8b05780 · Cited by 38
Kaushik, P., Henry, M. A., CLYNES, M. M., & Meleady, P. (2018) · Biotechnology Journal · doi:10.1002/biot.201700221 · Cited by 36
Model systems for analysis of dopamine transporter function and regulation
Hovde, M. J., Larson, G. H., Vaughan, R. A., & Foster, J. D. (2018) · Neurochemistry International · doi:10.1016/j.neuint.2018.08.015 · Cited by 37
“They are fastgrowing adherent cells having high transfection efficiency and the ability to produce significant levels of recombinant proteins (Lai et al., 2013; Wurm, 2004).”
BackgroundTorres, M., & Dickson, A. J. (2021) · Metabolic Engineering · doi:10.1016/j.ymben.2021.07.004 · Cited by 38
Wei, B., Woon, N., Dai, L., Fish, R., Tai, M., Handagama, W., Yin, A., Jia, S., Maier, A. J., McDaniel, D., et al. (2021) · mAbs · doi:10.1080/19420862.2021.2007564 · Cited by 39
“(South San Francisco, CA, USA).(49) Five stressed proteins (AAPH oxidation, low pH, high pH, light, and thermal stresses) were prepared in the Pharmaceutical Development department at Genentech (South San Francisco, CA, USA).”
Stutz, H. (2022) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2022.115089 · Cited by 38
“…(e.g., from Spodoptera frugiperda (Sf9, Sf21) [41,42] or from the moth Trichoplusia ni ( = High Five ™ cell line) [43]), and mammalian cell lines, for instance Chinese Hamster Ovary (CHO) cell lines [5,44, 45], Baby Hamster Kidney (BHK) cells [4,46,47], and murine myeloma cells (SP2/0, NS0) [4].”
BackgroundInfluentialLiu, J., Wang, J., Li, F., Chen, X., Hu, D., Deng, X., Poon, H. F., Wang, H., Liu, X., & Tan, W. (2015) · World Journal of Microbiology and Biotechnology · doi:10.1007/s11274-015-1864-8 · Cited by 42
“Mammalian cells, especially Chinese hamster ovary (CHO) cells, are commonly employed as the host for production of various therapeutically recombinant proteins because of their robust growth and ability to perform complex posttranslational modifications including glycosylation (Rasmussen et al. 1998; Wurm 2004).”
BackgroundMinimizing hydrodynamic stress in mammalian cell culture through the lobed Taylor‐Couette bioreactor
Sorg, R. A., Tanzeglock, T., Šoóš, M., Morbidelli, M., Périlleux, A., Solacroup, T., & Broly, H. (2011) · Biotechnology Journal · doi:10.1002/biot.201000477 · Cited by 38
Dorai, H., Nemeth, J. F., Cammaart, E., Wang, Y., Tang, Q. M., Magill, A., Lewis, M. J., Raju, T. S., Picha, K. M., O’Neil, K. T., et al. (2008) · Biotechnology and Bioengineering · doi:10.1002/bit.22217 · Cited by 41
“The majority of therapeutic proteins are being produced in mammalian cell culture systems or in Escherichia coli (reviewed in Walsh, 2005; Wurm, 2004).”
BackgroundLarge‐scale production of endotoxin‐free plasmids for transient expression in mammalian cell culture
Rozkov, A., Larsson, B., Gillström, S., Björnestedt, R., & Schmidt, S. R. (2007) · Biotechnology and Bioengineering · doi:10.1002/bit.21603 · Cited by 36
Data fusion‐based assessment of raw materials in mammalian cell culture
Lee, H. W., Christie, A., Xu, J., & Yoon, S. (2012) · Biotechnology and Bioengineering · doi:10.1002/bit.24548 · Cited by 37
Rodrigues, M. E., Costa, A. R., Henriques, M., Cunnah, P., Melton, D. W., Azeredo, J., & Oliveira, R. (2013) · Applied Biochemistry and Biotechnology · doi:10.1007/s12010-012-0068-z · Cited by 40
Crystallization of Proteins at Ultralow Supersaturations Using Novel Three-Dimensional Nanotemplates
Shah, U. V., Allenby, M. C., Williams, D. R., & Heng, J. Y. Y. (2012) · Crystal Growth & Design · doi:10.1021/cg201190c · Cited by 39
Production and Downstream Processing
Bergemann, K., Eckermann, C., Garidel, P., Grammatikos, S., Jacobi, A., Kaufmann, H., Kempken, R., & Pisch-Heberle, S. (2007) · Wiley eBooks · doi:10.1002/9783527619740.ch9 · Cited by 36
Fan, L., Frye, C. C., & Racher, A. J. (2013) · Pharmaceutical Bioprocessing · doi:10.4155/pbp.13.56 · Cited by 35
“121 Rajendra Y, Kiseljak D, Baldi L, Hacker DL, Wurm FM. A simple high-yielding process for transient gene expression in CHO cells. J. Biotechnol. 153(1–2), 22–26 (2011).”
BackgroundEngineering strategies for apoptotic bodies
Hu, Z., Qian, S., Zhao, Q., Lu, B., Lu, Q., Wang, Y., Zhang, L., Mao, X., Wang, D., Cui, W., et al. (2024) · Smart Medicine · doi:10.1002/smmd.20240005 · Cited by 37
Caron, A. W., Nicolas, C., Gaillet, B., Ba, I., Pinard, M., Garnier, A., Massie, B., & Gilbert, R. (2009) · BMC Biotechnology · doi:10.1186/1472-6750-9-42 · Cited by 49
“Advances in cell culture technologies, bioprocesses and metabolic engineering have remarkably increased yields of recombinant proteins produced by mammalian cells [1,2,4].”
BackgroundKawabe, Y., Makitsubo, H., Kameyama, Y., Huang, S., Itô, A., & Kamihira, M. (2011) · Cytotechnology · doi:10.1007/s10616-011-9397-y · Cited by 41
4-(1H-imidazol-1-yl) aniline: A new ligand of mixed-mode chromatography for antibody purification
Shi, Q., Zheng, C., & Sun, Y. P. (2009) · Journal of Chromatography A · doi:10.1016/j.chroma.2009.06.065 · Cited by 35
Functionalization of lactose as a biological carrier for bovine serum albumin by electrospraying
Cardoso, M. A. T., Talebi, M., Soares, P. A. M. H., Yurteri, C. Ü., & van Ommen, J. R. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.04.045 · Cited by 35
Dickson, A. J. (2014) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2014.06.004 · Cited by 40
Mead, E. J., Chiverton, L. M., Smales, C. M., & von der Haar, T. (2008) · Biotechnology and Bioengineering · doi:10.1002/bit.22201 · Cited by 35
CHOgenome.org 2.0: Genome resources and website updates
Kremkow, B. G., Baik, J. Y., MacDonald, M. L., & Lee, K. H. (2015) · Biotechnology Journal · doi:10.1002/biot.201400646 · Cited by 44
Fu, T., Zhang, C., Jing, Y., Jiang, C., Li, Z., Wang, S., Ma, K., Zhang, D., Hou, S., Dai, J., et al. (2016) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-016-7348-4 · Cited by 38
Somiya, M., Yoshioka, Y., & Ochiya, T. (2017) · AIMS bioengineering · doi:10.3934/bioeng.2017.1.73 · Cited by 40
Munro, T. P., Le, K., Le, H., Zhang, L., Stevens, J. L., Soice, N. P., Benchaar, S. A., Hong, R. W., & Goudar, C. T. (2017) · Biotechnology Progress · doi:10.1002/btpr.2572 · Cited by 36
“Many biologics rely on the use of mammalian cell-based production systems.(2) Typically, cells are genetically altered to express the gene of interest through the introduction of foreign DNA followed by a stringent selection step in which Correspondence concerning to this article should be addressed to T.”
BackgroundAssisting continuous biomanufacturing through advanced control in downstream purification
Papathanasiou, M. M., Burnak, B., Katz, J., Shah, N., & Pistikopoulos, E. N. (2019) · Computers & Chemical Engineering · doi:10.1016/j.compchemeng.2019.03.013 · Cited by 35
Jorgolli, M., Nevill, T., Winters, A. G., Chen, I., Chong, S., Lin, F., Mock, M. L., Chen, C., Le, K., Tan, C., et al. (2019) · Biotechnology and Bioengineering · doi:10.1002/bit.27024 · Cited by 41
“To select a cell line that will give high productivity, long‐term stability, and consistent product and process consistency, subcloning and extensive screening is required on hundreds of clonal cell lines, measuring growth, productivity and product quality in multiple screening assays (Wurm, 2004).”
Jiang, L., Jin, Y., & Marcus, R. K. (2015) · Journal of Chromatography A · doi:10.1016/j.chroma.2015.07.102 · Cited by 35
“[3] F.”
BackgroundChenuet, S., Martinet, D., Schmutz, N. B., Wicht, M., Jaccard, N., Bon, A., Derouazi, M., Hacker, D. L., Beckmann, J. S., & Wurm, F. M. (2008) · Biotechnology and Bioengineering · doi:10.1002/bit.21972 · Cited by 35
“Correspondence to: F.M. Wurm 2008 Wiley Periodicals, Inc. Stable gene expression from recombinant cell lines remains the major approach to the production of proteins in mammalian cells (see Wurm, 2004 for review).”
BackgroundSelf-citationBaik, J. Y., Dahodwala, H., Oduah, E., Talman, L., Gemmill, T. R., Gasimli, L., Datta, P., Yang, B., Li, G., Zhang, F., et al. (2015) · Biotechnology Journal · doi:10.1002/biot.201400665 · Cited by 37
“The transition from batch to fed-batch processes has resulted in greater than 20-fold increases in IVCD and nearly 100-fold increases in yield [32].”
‘Zipbody’ leucine zipper-fused Fab in E. coli in vitro and in vivo expression systems
Ojima-Kato, T., Fukui, K., Yamamoto, H., Hashimura, D., Miyake, S., Hirakawa, Y., Yamasaki, T., Kojima, T., & Nakano, H. (2016) · Protein Engineering Design and Selection · doi:10.1093/protein/gzw001 · Cited by 35
Large-Scale Transfection of Mammalian Cells
Baldi, L., Hacker, D. L., Meerschman, C., & Wurm, F. M. (2011) · Methods in molecular biology · doi:10.1007/978-1-61779-352-3_2 · Cited by 34
Self-citation
Metadata
- Authors
- Wurm, F. M.
- Affiliations
- École Polytechnique Fédérale de Lausanne (CH)
- Corresponding author
- Wurm, Florian M
- ORCID
- Wurm, Florian M
- Venue
- Nature Biotechnology
- Published
- 2004-11
- Volume
- 22
- Issue
- 11
- Pages
- 1393-1398
- ISSN
- 0733-222X (ISSN-L)
- 1087-0156
- 1546-1696
- OpenAlex
- W2118540273
- Cited by
- 2,032
- References
- 52
- Citations by year
- 2026: 52 · 2025: 51 · 2024: 66 · 2023: 66 · 2022: 64 · 2021: 77 · 2020: 89 · 2019: 114 · 2018: 162 · 2017: 118 · 2016: 95 · 2015: 135 · 2014: 108 · 2013: 145 · 2012: 111
- FWCI
- 3.67
- Type
- journal article
- Language
- en
- Open access
- green
- infoscience.epfl.ch
- Licence
- cc-by-nc-nd
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature Biotechnology (publishedVersion)
- PubMed (publishedVersion)
- Infoscience (Ecole Polytechnique Fédérale de Lausanne) (submittedVersion, cc-by-nc-nd)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Viral Infectious Diseases and Gene Expression in Insects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein purification and stability
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biotechnology › Transgenic Plants and Applications
- Keywords
- recombinant therapeutic proteins, mammalian cell culture, bioreactors, protein folding, post-translational modification, volumetric productivity, culture medium optimization, process control, vector engineering, host cell engineering
- MeSH terms
- Animals, Cells, Cultured, Humans, Mammals, Recombinant Proteins, Transfection, Protein Engineering, Cell Culture Techniques, Bioreactors, Genetic Enhancement
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.